Novartis Farma - Pharmaceutical Products, S.A. Novartis Farma S.p.A. Novartis Pharmaceutical, S.A. Novartis (Hellas) S.A. Novartis Hungary Ltd. Novartis Pharma B.V. Novartis Pharma Ltd. Novartis Pharma Ltd. Novartis Pharma S.A.S. Novartis Sweden Ltd.

Poland

All drugs from this manufacturer

  • SANDOSTATIN LAR

    The medicine is used to treat acromegaly (a disease related to excess growth hormone), to relieve symptoms associated with excessive hormone secretion by the stomach, intestines, and pancreas, to treat intestinal neuroendocrine tumors, and to treat pituitary tumors that secrete excessive amounts of TSH hormone.

    Dosage form: powder and solvent for preparation of suspension for injection

    Active substance Dosage
    octreotide acetate 11.2 mg

    ATC: H01CB02